Repaglinide is an oral antidiabetic medication belonging to the class of drugs known as meglitinides. It is primarily prescribed for the management of type 2 diabetes mellitus, particularly in patients who experience postprandial hyperglycemia. Repaglinide exerts its therapeutic effects by targeting the pancreatic beta cells and enhancing insulin s
39 Reached
Complicated case of Osteoarthritis
1849 Reached2 Comments3 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Resistant Thyrotoxicosis in Pregnancy
1332 Reached4 Comments2 Likes
Pancytopenia, a rare presentation of hyperthyroidism
825 Reached2 Comments
Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes